These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17617377)

  • 1. DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation.
    Collado D; Yoshihara T; Hamaguchi M
    Biochem Biophys Res Commun; 2007 Aug; 360(3):600-3. PubMed ID: 17617377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function.
    Yoshihara T; Collado D; Hamaguchi M
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1076-9. PubMed ID: 17517369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
    Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
    Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.
    Zhang Q; Tian L; Mansouri A; Korapati AL; Johnson TJ; Claret FX
    FEBS Lett; 2005 Jul; 579(18):3932-40. PubMed ID: 15996662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells.
    Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H
    Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the DBC2 gene and its clinicopathological significance in breast cancer: correlation with aberrant DNA methylation.
    Han L; Hou L; Song J; Lin D; Wu L; Ge Y; Ma Z
    Biotechnol Lett; 2013 Aug; 35(8):1175-81. PubMed ID: 23546941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways.
    Siripurapu V; Meth J; Kobayashi N; Hamaguchi M
    J Mol Biol; 2005 Feb; 346(1):83-9. PubMed ID: 15663929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complex.
    Manjarrez JR; Sun L; Prince T; Matts RL
    PLoS One; 2014; 9(3):e90054. PubMed ID: 24608665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoBTB2 (DBC2) comes of age as a multifunctional tumor suppressor.
    Freeman SN; Cress WD
    Cancer Biol Ther; 2010 Dec; 10(11):1123-5. PubMed ID: 20980811
    [No Abstract]   [Full Text] [Related]  

  • 10. DBC2 is essential for transporting vesicular stomatitis virus glycoprotein.
    Chang FK; Sato N; Kobayashi-Simorowski N; Yoshihara T; Meth JL; Hamaguchi M
    J Mol Biol; 2006 Dec; 364(3):302-8. PubMed ID: 17023000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
    Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
    Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DBC2 gene is silenced by promoter methylation in bladder cancer.
    Shi Y; Chen JY; Yang J; Li B; Chen ZH; Xiao CG
    Urol Oncol; 2008; 26(5):465-9. PubMed ID: 18640857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
    Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
    Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DBC2, a candidate for a tumor suppressor gene involved in breast cancer.
    Hamaguchi M; Meth JL; von Klitzing C; Wei W; Esposito D; Rodgers L; Walsh T; Welcsh P; King MC; Wigler MH
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13647-52. PubMed ID: 12370419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
    Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
    Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse homologue of yeast Prp19 interacts with mouse SUG1, the regulatory subunit of 26S proteasome.
    Sihn CR; Cho SY; Lee JH; Lee TR; Kim SH
    Biochem Biophys Res Commun; 2007 Apr; 356(1):175-80. PubMed ID: 17349974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tumor suppressor gene RhoBTB2 (DBC2): frequent loss of expression in sporadic breast cancer.
    Mao H; Qu X; Yang Y; Zuo W; Bi Y; Zhou C; Yin H; Deng B; Sun J; Zhang L
    Mol Carcinog; 2010 Mar; 49(3):283-9. PubMed ID: 19937980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different induction of GRP78 and CHOP as a predictor of sensitivity to proteasome inhibitors in thyroid cancer cells.
    Wang HQ; Du ZX; Zhang HY; Gao DX
    Endocrinology; 2007 Jul; 148(7):3258-70. PubMed ID: 17431003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.